CARLSBAD, Calif., July 7 /PRNewswire-FirstCall/ -- Alphatec Holdings, Inc. , a medical device company that provides customized spinal products and a broad suite of spine fusion solutions, today announced plans to release its results for the second quarter and six months ended June 30, 2006, before the market opens on Thursday, July 27, 2006. The Company’s management will host a conference call to be broadcast live on the Internet at 11:30 am EDT that day.
Management encourages shareholders and other interested parties to listen to the live webcast by going to the Company’s website at www.alphatecspine.com. Web participants should go to the Company’s website at least 15 minutes prior to the start of the call to register, download, and install any necessary audio software. The online archive of the call will be available immediately following the conference call.
About Alphatec
Alphatec is a medical device company focused on the design, development, manufacturing and marketing of products for the surgical treatment of spine disorders. Alphatec’s principal product offering is primarily focused on the estimated $2.2 billion U.S. spine fusion market through its wholly-owned subsidiary, Alphatec Spine, Inc., and includes a variety of spinal implant products and systems comprised of components such as spine screws, spinal spacers, and plates that offer multiple solutions to address patients’ needs. In addition to Alphatec’s U.S. presence, it also participates in the Japanese spine fusion and orthopedic trauma markets through its subsidiary, Alphatec Pacific, Inc. Our mission is to be a value based leader in the spinal market by providing unmatched service to and taking scientific direction from our physician customers. We do so through our unique in-house manufacturing facility in Carlsbad, California that allows us to respond quickly and to customize innovative products needed for spine fusion surgery.
Forward Looking Statements
The statements herein regarding Alphatec contain forward-looking statements that involve risks and uncertainty. Future events and Alphatec’s actual results could differ materially from the results reflected in these forward-looking statements. Factors that might cause such a difference include, but are not limited to, Alphatec’s ability to develop and expand its spine fusion business in the United States and Japan, Alphatec’s ability to expand and maintain a successful sales and marketing organization, continuation of favorable third party payor reimbursement for procedures performed using our products, unanticipated expenses or liabilities or other adverse events affecting cash flow, uncertainty of success in developing any new products, failure to successfully introduce new products related to license agreements, failure to obtain FDA clearance or approval for particular devices, Alphatec’s ability to compete with other competing products and with emerging new technologies within and outside of spinal fusion, and the risks detailed in Alphatec’s Form S-1 on file with the SEC, as well as the risks detailed from time to time in Alphatec’s SEC reports, including quarterly reports on Form 10-Q, reports on Form 8-K and annual reports on Form 10-K.
Alphatec does not assume any obligation to update any forward-looking statements or other information contained in this document.
Alphatec Holdings, Inc.
CONTACT: Matt Clawson of Allen & Caron, Inc., +1-949-474-4300,matt@allencaron.com, for Alphatec Holdings, Inc.; or Stephen T. D. Dixon,Vice President and CFO of Alphatec Holdings, Inc., +1-760-431-9286
Web site: http://www.alphatecspine.com/
